Table 1 Differentially expressed genes between galectin-3 transfectants and vehicle control

Table 1. Selected regulated genes in NHEK and SCC12B2 in response to UVB irradiation

Table 2. The 89 genes for which expression levels differed between HBV-HCCs from patients with LC and those without LC

Table 1. Differential gene expression detected by cDNA array analysis

Table 3. Effects of p53 status and topotecan treatment on gene expression for the 167 most consistently responsive genes

Table 1 Candidate Wnt pathway target genes in OEA

Figure 2. TreeView of P<0.01 SG up- or down-regulated greater than twofold in 18 high tumor burden patients (red) compared with 9 Th2-skewed controls (blue).

Table S3a.ÿSignature Membership Unique Genes: ARHB Signature Genes

Table S3b.ÿSignature Membership Unique Genes: CD1D \CD1D antigen  d polypeptide\" Signature Genes"

Table S3c.ÿSignature Membership Unique Genes: FDFT1 farnesyl-diphosphate farnesyltransferase 1 Signature Genes

Table 5.39 genes distinguish mutant N-Ras transfectants from all other treatments

Table 4.Top 50 of 157 most differentially expressed genes in a comparison of N-ras-activating mutation and stroma response

Table 1.Top 50 of 138 most differentially expressed genes in a comparison of IL-6 response versus IL-6 starvation effect

Table 2.Top 50 of 87 most differentially expressed genes in a comparison of stroma stimulation and IL-6 response

Table 3.Top 50 of 130 most differentially expressed genes in a comparison of N-ras-activating mutation and IL-6 response

Table 5. Genes differentially regulated in after immortalization and demethylation following treatment of immortal LFS fibroblasts with 5AZA-dC. This results in arrest of growth of the  Li–Fraumeni syndrome fibroblasts and development of a senescent phenotype through methylation-dependent gene silencing.  Li–Fraumeni syndrome (LFS) is a familial cancer syndrome that is characterized by multiple primary tumors including soft-tissue sarcomas  osteosarcomas  breast carcinomas  brain tumors  leukemias  adrenalcortical carcinomas  to a lesser extent melanoma and carcinomas of the lung  pancreas  and prostate.